3 November 2023 in Biomolecules and Biomedicine
Current research supports the evidence that the gut microbiome (GM), which consist of gut microbiota and their biologically active metabolites, is associated with atherosclerosis development. Trimethylamine-N-oxide (TMAO), a metabolite produced by the GM through trimethylamine (TMA) oxidation, significantly enhances the formation and vulnerability of atherosclerotic plaques. TMAO promotes inflammation and oxidative stress in endothelial cells, leading to vascular dysfunction and plaque formation. Dimethyl-1-butanol (DMB), iodomethylcholine (IMC) and fluoromethylcholine (FMC) have been recognized for their ability to reduce plasma TMAO by inhibiting trimethylamine lyase, a bacterial enzyme involved in the choline cleavage anaerobic process, thus reducing TMA formation. Conversely, indole-3-carbinol (I3C) and trigonelline inhibit TMA oxidation by inhibiting flavin-containing monooxygenase-3 (FMO3), resulting in reduced plasma TMAO. The combined use of inhibitors of choline trimethylamine lyase and flavin-containing monooxygenase-3 could provide novel therapeutic strategies for cardiovascular disease prevention by stabilizing existing atherosclerotic plaques. This review aims to present the current evidence of the roles of TMA/TMAO in atherosclerosis as well as its potential therapeutic prevention aspects.
10 January 2026 in JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
Highlights: Rheumatic heart disease remains a significant health concern in low-and middle-income countries, as it is often challenging to detect in its early stages due to subtle or absent symptoms, particularly during the subclinical phase. Task-shifting echocardiographic screening of RHD to GPs offers a scalable solution in low-resource settings. Abstract Introduction: Rheumatic heart disease (RHD) remains a significant health burden in low- and middle-income countries. Early detection of RHD by trained general practitioners (GPs) enables earlier intervention to prevent disease progression. This study aimed to evaluate the feasibility and effectiveness of training non-expert health workers in Indonesia to perform echocardiographic screening for RHD, addressing the country’s unique challenges and bridging the gap in healthcare resources. Methods: A quasi-experimental pre-post intervention study was conducted involving 18 GPs with no prior echocardiography experience. The training consisted of one day of lecture-based instruction and six days of supervised hands-on practice. Knowledge was assessed using a newly developed RHD-echocardiography test that underwent face and content validation by two cardiologists and demonstrated good internal consistency (Cronbach’s alpha = 0.82). Pre- and post-training knowledge was compared using paired t-tests. Diagnostic sensitivity and specificity were calculated using cardiologist-confirmed findings from a subsequent one-month school-based screening of 440 students. Results: The mean pre-test score was 64 ± 11, significantly increasing to 95 ± 7.5 after training (p<0.001). Image quality was diagnostically adequate in 97.7% of examinations. Sensitivity and specificity of GP-acquired screening echocardiograms were 41.4% (95% Confidence Interval/CI: 29.9%-53.0%) and 73.7% (95% CI: 69.1%-78.3%), respectively. No significant differences in scores were observed by gender or age group. Conclusion: Although participants initially had limited exposure to echocardiography, the structured short-term curriculum substantially improved knowledge, image acquisition skills, and screening capability. Task-shifting echocardiographic screening to mid-level providers appears feasible in Indonesia and warrants further refinement and scale-up.